肝胆肿瘤疾病智能化诊疗模式的发展及启示

王晓云; 李林峰; 郭佺; 曾义岚; 李海洋; 杜映荣; 陈刚; 梁跃东; 陆荫英

doi:10.3969/j.issn.1001-5256.2019.10.051

肝胆肿瘤疾病智能化诊疗模式的发展及启示

DOI: 10.3969/j.issn.1001-5256.2019.10.051

1 医渡云（北京）技术有限公司
2. 北京交通大学计算机与信息技术学院
3. 成都市公共卫生临床医疗中心肝病科
4. 贵州医科大学附属医院院办
5. 云南省昆明市第三人民医院院办
6. 太原市第三人民医院院办
7. 贵阳市公共卫生救治中心院办
8. 解放军总医院第五医学中心肝脏肿瘤诊疗与研究中心

基金项目:

国家重点研发计划精准医学研究重点专项(2017YFC0908401)；艾滋病和病毒性肝炎等重大传染病防治科技重大专项(2018ZX10723-204-007-002)；

详细信息

中图分类号: R735
计量
- 文章访问数: 1289
- HTML全文浏览量: 38
- PDF下载量: 287
- 被引次数: 0
出版历程
- 收稿日期: 2019-05-31
- 出版日期: 2019-10-20

Development and enlightenment of intelligentized diagnostic and therapeutic mode for hepatobiliary tumors

Yidu Cloud(Beijing) Technology co,ltd

Research funding:

摘要

摘要: 建立临床决策支持系统(CDSS)和多学科协作(MDT)模式是提高医疗效率和质量的重要措施。从国内外CDSS和MDT发展现状进行概述和分析,总结其特点与不足,同时结合"医疗大数据资源"及"大数据技术"的时代背景,对发展适合我国国情的肝胆肿瘤智能化诊疗平台—"联合CDSS和MDT"提出了展望。
- 肝肿瘤 /
- 胆道肿瘤 /
- 决策支持系统,临床 /
- 肿瘤治疗方案 /
- 综合疗法
Abstract: Clinical decision support system(CDSS) and multidisciplinary team(MDT) are important measures to improve the efficiency and quality of healthcare service. This article reviews and analyzes the current status of the development of CDSS and MDT in China and foreign countries and summarizes their features and shortcomings,and with the background of the new era of“medical big data resources”and“big data technology”,this article looks into the future of developing an intelligentized diagnostic and therapeutic mode(a combination of CDSS and MDT) for hepatobiliary tumors suitable for the national conditions of China.
- liver neoplasms /
- biliary tract neoplasms /
- decision support systems,clinical /
- antineoplastic protocols /
- combined modality therapy

HTML全文

参考文献(30)

[1] LI DN. Current development status and future trends of the healthcare industry in the background of the“Healthy China”strategy[J]. Econ Res Guide,2018,20:42-43.(in Chinese)李达宁.“健康中国”战略背景下医疗健康产业的发展现状及变革趋势分析[J].经济研究导刊,2018,20:42-43.

[2] KOUTKIAS V,BOUAUD J. Contributions from the 2017 literature on clinical decision support[J]. Year Med Inform,2018,27(1):122-128.

[3] MENG Q. Construct the new service mode of“Internet+Healthcare”and establish the new order of hierarchical diagnosis and treatment[J]. Chin J Health Inform Manag,2017,14(2):101.(in Chinese)孟群.构建“互联网+健康医疗”服务新模式打造分级诊疗就医新秩序[J].中国卫生信息管理杂志,2017,14(2):101.

[4] DONG J,WANG X,LI J,et al. Clinical decision support system and application[J]. Chin Health Quality Manage,2016,23(3):16-19.(in Chinese)董军,王欣,李军,等.临床决策支持系统的构建与应用[J].中国卫生质量管理,2016,23(3):16-19.

[5] KONG G,XU DL,YANG JB. Clinical decision support systems:A review of knowledge representation and inference under uncertainties[J]. Int J Comput Int Sys,2008,1(2):159-167.

[6] ALEXANDER S,ANTON B,DAVID S,et al. Clinical decision support and individualized prediction of survival in colon cancer:Bayesian belief network model[J]. Ann Surg Oncol,2013,20(1):161-174.

[7] Bureau of Medical Administration,National Health and Family Planning Commission of the People’s Republic of China. Notice on implementing the pilot work of multidisciplinary tumor diagnosis and treatment[EB/OL].[2018-08-27]http://www. nhc. gov. cn/yzygj/s3594q/201808/0cfe48391dd14876951cf6262e28c062. shtml.(in Chinese)中国医政医管局.关于开展肿瘤多学科诊疗试点工作的通知[EB/OL].[2018-08-27]http://www. nhc. gov. cn/yzygj/s3594q/201808/0cfe48391dd14876951cf6262e28c062. shtml.

[8] GAO Y,SHAO YC,SU MZ,et al. Advances in the research of multidisciplinary team cooperative diagnosis and treatment model for cancer patients[J]. Chin Hosp Manage,2019,39(3):34-37.(in Chinese)高扬,邵雨辰,苏明珠,等.癌症患者的多学科团队协作诊疗模式研究进展[J].中国医院管理,2019,39(3):34-37.

[9] ZHENG SW,MA JH,YIN SQ,et al. Developing a multidisciplinary team model in management of patients cancer diagnosis and treatment[J]. China Cancer,2017,26(9):661-664.(in Chinese)郑舒文,马建辉,尹世全,等.恶性肿瘤多学科综合诊疗模式的探索[J].中国肿瘤,2017,26(9):661-664.

[10] SUN X. Efforts are needed to implement the model of multidisciplinary outpatient consultation[J]. China Hospital CEO,2017,Z1:32-33.(in Chinese)孙茜.多学科门诊会诊做实模式仍需努力[J].中国医院院长,2017,Z1:32-33.

[11] LAMB BW,BROWN KF,NAGPAL K,et al. Quality of care management decisions by multidisciplinary cancer teams:A systematic review[J]. Ann Surg Oncol,2011,18(8):2116.

[12] PATKAR V,ACOSTA D,DAVIDSON T,et al. Cancer multidisciplinary team meetings:Evidence,challenges,and the role of clinical decision support technology[J]. Int J Breast Cancer,2011,2011:831605.

[13] ARUN S,AMARNATH B,ATISH S,et al. Clinical decision support:Converging toward an integrated architecture[J]. J Biomed Inform,2012,45(5):1009-1017.

[14] LANCELEY A,SAVAGE J,MENON U,et al. Influences on multidisciplinary team decision-making[J]. Int J Gynecol Cancer,2010,18(2):215-222.

[15] SESEN MB,PEAKE MD,BANARES-ALCANTARA R,et al.Lung cancer assistant:A hybrid clinical decision support application for lung cancer care[J]. J R Soc Interface,2014,11(98):81-101.

[16] NORTON JA,FOSTER DS,BLUMGART LH,et al. Incidence and prognosis of primary gastrinomas in the hepatobiliary tract[J]. JAMA Surg,2018,153(3):e175083.

[17] European Association for the Study of the Liver. EASL clinical practice guidelines:Management of hepatocellular carcinoma[J]. J Hepatol,2018,69(1):182-236.

[18] ZHENG RS,SUN KX,ZHANG SW,et al. Report of cancer epidemiology in China,2015[J]. Chin J Oncol,2019,41(1):19-28.(in Chinese)郑荣寿,孙可欣,张思维,等. 2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2019,41(1):19-28.

[19] CHEN W,ZHENG R,BAADE PD,et al. Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66(2):115-132.

[20] CURTIUS K,WRIGHT NA,GRAHAM TA. An evolutionary perspective on field cancerization[J]. Nat Rev Cancer,2018,18(1):19.

[21] DONG LQ,SHI Y,MA LJ,et al. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma[J]. J Hepatol,2018,69(1):89-98.

[22] GE NL. Importance of collaborative diagnosis and treatment mode for hepatocellular carci-noma multidisciplinary team(MDT)[J].Chin J Gastroenterol Hepatol,2018,27(6):11-14.(in Chinese)葛宁灵.肝细胞癌多学科团队(MDT)协作诊疗模式的重要性[J].胃肠病学和肝病学杂志,2018,27(6):11-14.

[23] PATKAR V,ACOSTA D,DAVIDSON T,et al. Using computerised decision support to improve compliance of cancer multidisciplinary meetings with evidence-based guidance[J].BMJ Open,2012,2(3). pii:e000439.

[24] ACOSTA D,PATKAR V,MO K,et al. Challenges in delivering decision support systems:The MATE experience[C]//Aime International Conference on Knowledge Representation for Health-care:Data,Verona,Italy,2010.

[25] Guidance for promoting and standardizing the application and development of healthcare big data by the General Office of the State Council of the People’s Republic of China[EB/OL](2016-06-24). http://www. gov. cn/xinwen/2016-06/24/content_5085211. htm.(in Chinese)国务院办公厅发关于促进和规范健康医疗大数据应用发展的指导意见[EB/OL](2016-06-24). http://www. gov. cn/xinwen/2016-06/24/content_5085211. htm.

[26] LIN FP,POKORNY A,TENG C,et al. Computational prediction of multidisciplinary team decision-making for adjuvant breast cancer drug therapies:A machine learning approach[J]. BMC Cancer,2016,16(1):929.

[27] RAJESWARI K,VAITHIYANATHAN V,ABIN D. Artificial intel igence(AI)techniques applied for the development of a clinical decision support system(CDSS)for diagnosing ischemic Heart disease(IHD)[J]. Int J Comput Appl,2014,9:28-37.

[28] SITAPATI A,KIM H,BERKOVICH B,et al. Integrated precision medicine:The role of electronic health records in delivering personalized treatment[J]. Wiley Interdiscip Rev Syst Biol Med,2017,9(3):e1378.

[29] ZHOU YJ,XIANG MF,LI T. Application of big medical data in cancer diagnosis and treatment[J]. J Int Oncol,2016,43(1):75-78.(in Chinese)周殷杰,向明飞,李涛.医疗大数据在恶性肿瘤诊治中的应用[J].国际肿瘤学杂志,2016,43(1):75-78.

[30] MOJA L,PASSARDI A,CAPOBUSSI M,et al. Implementing an evidence-based computerized decision support system linked to electronic health records to improve care for cancer patients:The ONCO-CODES study protocol for a randomized controlled trial[J]. Implement Sci,2016,11(1):153.

施引文献

资源附件(0)

访问统计